ACT Genomics received the 2021 Frost & Sullivan Best Practices Award in Asia-pacific Clinical Oncology Next-generation Sequencing Workflow Solutions Product Leadership. Nidhi Jalali, Frost and Sullivan Best Practices Analyst says “ACT Genomics, with the help of local laboratories in Taiwan, Hong Kong, and Japan, is integrating NGS technology into wet and dry lab data analysis applications to address APAC’s hospital outsourcing needs. By offering cancer diagnostic tests that meet world-class quality standards, in addition to compiling and curating the largest genomic cancer database addressing the Asian population, the company emerges as an industry standout.” Read more: